TCL Archive Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival March 28, 2014
TCL Archive New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics December 10, 1999